Hot Features
Alpha Teknova, Inc. produces critical reagents for the discovery, development, and commercialization of novel therapies, vaccines, and molecular diagnostics in the United States and internationally. The company’ primary products include pre-poured media plates for cell growth and cloning; liquid mic... Alpha Teknova, Inc. produces critical reagents for the discovery, development, and commercialization of novel therapies, vaccines, and molecular diagnostics in the United States and internationally. The company’ primary products include pre-poured media plates for cell growth and cloning; liquid microbial culture media and supplements for cellular expansion; and molecular biology reagents for sample manipulation, resuspension, and purification. It provides lab essentials which provides chemical formulations for use in biological research and drug discovery; and clinical solutions, a custom product used in the development and production of protein therapies, gene therapies, mRNA vaccines, and diagnostic kits. The company serves its products to life sciences market, including pharmaceutical and biotechnology companies, contract development and manufacturing organizations, in vitro diagnostic franchises, as well as academic and government research institutions. Alpha Teknova, Inc. was founded in 1996 and is headquartered in Hollister, California. Show more
| Période | Variation | Variation % | Ouver. | Haut | Bas | Moyenne Vol. Quot. | VWAP | |
|---|---|---|---|---|---|---|---|---|
| 1 | -0.08 | -1.72413793103 | 4.64 | 5.78 | 4.49 | 245836 | 5.32007351 | CS |
| 4 | 0.55 | 13.7157107232 | 4.01 | 5.78 | 3.38 | 159070 | 4.49822748 | CS |
| 12 | 1.89 | 70.7865168539 | 2.67 | 5.78 | 2.55 | 128468 | 3.63272678 | CS |
| 26 | -0.24 | -5 | 4.8 | 5.78 | 1.91 | 184978 | 3.21139282 | CS |
| 52 | -1.24 | -21.3793103448 | 5.8 | 6.68 | 1.91 | 223587 | 4.26736672 | CS |
| 156 | 0.57 | 14.2857142857 | 3.99 | 10.37 | 1.155 | 224108 | 4.70195254 | CS |
| 260 | -16.16 | -77.9922779923 | 20.72 | 30.89 | 1.155 | 166706 | 6.39062646 | CS |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales
Vous avez déjà un compte? Connexion
Vous n'avez pas de compte ? Inscription
En m'inscrivant, je confirme avoir lu, compris et accepté les Conditions générales d'ADVFN et j'affirme etre un investisseur privé.